New hope for stubborn high blood pressure: drug targets vessel function
NCT ID NCT04388124
First seen Mar 06, 2026 · Last updated May 22, 2026 · Updated 12 times
Summary
This study tests whether a drug that blocks endothelin-1 receptors can improve blood vessel function and lower blood pressure in people with resistant hypertension (high blood pressure that doesn't respond to standard treatments). About 24 adults aged 30-80 will take the drug for 8 weeks. The goal is to see if it helps blood vessels work better and is safe for the kidneys.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESISTANT HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chu Rouen
RECRUITINGRouen, 76031, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.